You are here Home Resources and guidance Sponsors BeiGene AUS Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Prescription medicine decision summary (2) Prescription medicine registration (2) Designation or determination (1) Date (-) 2021 (5) 2025 (3) 2024 (5) 2023 (2) 2022 (3) 2020 (1) Search Filters applied:2021Clear all Sponsor content5 result(s) found, displaying 1 to 5 Brukinsa 20 October 2021 Prescription medicine decision summary Australian prescription medicine decision summary Brukinsa 15 October 2021 Prescription medicine decision summary Australian prescription medicine decision summary BRUKINSA (Beigene Aus Pty Ltd) 8 October 2021 Prescription medicine registration Active ingredients: zanubrutinib. BRUKINSA (Beigene Aus Pty Ltd) 7 October 2021 Prescription medicine registration Active ingredients: zanubrutinib. Notice for zanubrutinib (BeiGene AUS Pty Ltd) 20 September 2021 Designation or determination Provisional approval
Brukinsa 20 October 2021 Prescription medicine decision summary Australian prescription medicine decision summary
Brukinsa 15 October 2021 Prescription medicine decision summary Australian prescription medicine decision summary
BRUKINSA (Beigene Aus Pty Ltd) 8 October 2021 Prescription medicine registration Active ingredients: zanubrutinib.
BRUKINSA (Beigene Aus Pty Ltd) 7 October 2021 Prescription medicine registration Active ingredients: zanubrutinib.
Notice for zanubrutinib (BeiGene AUS Pty Ltd) 20 September 2021 Designation or determination Provisional approval